CELLDEX THERAPEUTICS INC (CLDX) Forecast, Price Target & Analyst Ratings

NASDAQ:CLDX • US15117B2025

Current stock price

30.03 USD
+1.49 (+5.22%)
At close:
30.03 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CELLDEX THERAPEUTICS INC (CLDX).

Forecast Snapshot

Consensus Price Target

Price Target
$51.17
+ 70.40% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
-$1.14
Revenue Estimate
1.134M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
80.91%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$51.17
Upside
+ 70.40%
From current price of $30.03 to mean target of $51.17, Based on 22 analyst forecasts
Low
$24.24
Median
$46.41
High
$94.50

Price Target Revisions

1 Month
-4.09%
3 Months
-5.60%

Price Target Summary

22 Wall Street analysts provided a forecast for the next 12 months for CLDX. The average price target is 51.17 USD. This implies a price increase of 70.4% is expected in the next year compared to the current price of 30.03.
The average price target has been revised downward by 5.6% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

CLDX Current Analyst RatingCLDX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

CLDX Historical Analyst RatingsCLDX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
80.91%
CLDX was analyzed by 22 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about CLDX.
In the previous month the buy percentage consensus was at a similar level.
CLDX was analyzed by 22 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-02Goldman SachsMaintains Neutral -> Neutral
2026-02-26StifelReiterate Buy -> Buy
2025-12-17BarclaysMaintains Underweight -> Underweight
2025-11-11BarclaysMaintains Underweight -> Underweight
2025-10-21MizuhoInitiate Outperform
2025-10-13BarclaysInitiate Underweight
2025-09-17Canaccord GenuityMaintains Buy -> Buy
2025-08-20Wells FargoMaintains Overweight -> Overweight
2025-08-20Canaccord GenuityMaintains Buy -> Buy
2025-08-20CitigroupMaintains Buy -> Buy
2025-08-20HC Wainwright & Co.Maintains Buy -> Buy
2025-06-16HC Wainwright & Co.Reiterate Buy -> Buy
2025-06-13HC Wainwright & Co.Reiterate Buy -> Buy
2025-05-09UBSMaintains Buy -> Buy
2025-05-09Goldman SachsMaintains Neutral -> Neutral
2025-05-09Morgan StanleyMaintains Overweight -> Overweight
2025-05-09HC Wainwright & Co.Maintains Buy -> Buy
2025-05-06HC Wainwright & Co.Reiterate Buy -> Buy
2025-04-28Canaccord GenuityInitiate Buy
2025-03-20Morgan StanleyInitiate Overweight
2025-03-03Goldman SachsMaintains Neutral -> Neutral
2025-03-03HC Wainwright & Co.Reiterate Buy -> Buy
2025-02-28HC Wainwright & Co.Reiterate Buy -> Buy
2025-02-13UBSInitiate Buy
2025-01-29Cantor FitzgeraldReiterate Overweight -> Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
-$1.14
Revenue Estimate
1.134M
Revenue Q2Q
63.17%
EPS Q2Q
-40.67%
Number of Analysts
14

Next Earnings Revisions

Revenue (1 Month)
56.59%
Revenue (3 Months)
70.52%
EPS (1 Month)
-2.60%
EPS (3 Months)
-4.40%

Next Earnings Summary

CLDX is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is -1.14 USD and the consensus revenue estimate is 1.13M USD.
The next earnings revenue estimate has been revised upward by 70.52% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
CLDX revenue by date.CLDX revenue by date.
6.883M
191.65%		7.02M
1.99%		1.545M
-77.99%		3.053M
97.61%		10.747M
252.01%		151.6M
1,310.63%		480.72M
217.10%		908.73M
89.04%		1.161B
27.76%		1.575B
35.66%		2.074B
31.68%
EBITDA
YoY % growth
CLDX ebitda by date.CLDX ebitda by date.
-139.034M
-42.85%		-191.901M
-38.02%		-283.987M
-47.99%		-350.326M
-23.36%		-408.526M
-16.61%		-275.787M
32.49%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
CLDX ebit by date.CLDX ebit by date.
-142.042M
-41.72%		-195.078M
-37.34%		-287.367M
-47.31%		-324.613M
-12.96%		-367.576M
-13.24%		-246.3M
32.99%		1.768M
100.72%		328.8M
18,497.29%		548.05M
66.68%		786.15M
43.44%		1.028B
30.76%
Operating Margin
CLDX operating margin by date.CLDX operating margin by date.
-2,063.66%-2,778.89%-18,599.81%-10,632.58%-3,420.27%-162.47%0.37%36.18%47.20%49.91%49.57%
EPS
YoY % growth
CLDX eps by date.CLDX eps by date.
-2.91
-31.67%		-2.45
15.81%		-3.89
-58.78%		-4.76
-22.28%		-4.79
-0.65%		-3.19
33.40%		-1.40
56.01%		1.89
234.73%		3.20
69.23%		7.12
122.81%		11.09
55.69%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-1.14
-40.67%		-1.19
-40.07%		-1.17
-16.10%		-1.14
6.24%
Revenue
Q2Q % growth		1.134M
63.17%		991.95K
35.88%		809.197K831.3K
587.02%
EBITDA
Q2Q % growth		-79.846M
-29.05%		-68.591M
-10.42%		-70.357M
0.98%		N/A
EBIT
Q2Q % growth		-84.958M
-35.41%		-84.519M
-32.36%		-81.117M
-10.19%		-84.852M
2.64%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CLDX Yearly Revenue VS EstimatesCLDX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B 2B
CLDX Yearly EPS VS EstimatesCLDX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 10 -10 -20

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
5.68%
EPS Next 5 Year
19.98%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
289.73%
Revenue Next 5 Year
223.60%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
0.04%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

CELLDEX THERAPEUTICS INC / CLDX Forecast FAQ

What do analysts expect the price target to be for CELLDEX THERAPEUTICS INC (CLDX)?

22 analysts have analysed CLDX and the average price target is 51.17 USD. This implies a price increase of 70.4% is expected in the next year compared to the current price of 30.03.

Can you provide the upcoming earnings date for CELLDEX THERAPEUTICS INC?

CELLDEX THERAPEUTICS INC (CLDX) will report earnings on 2026-05-06.

What are the consensus estimates for CLDX stock next earnings?

The consensus EPS estimate for the next earnings of CELLDEX THERAPEUTICS INC (CLDX) is -1.14 USD and the consensus revenue estimate is 1.13M USD.

Can you provide the expected long term growth rate for CELLDEX THERAPEUTICS INC stock?

The expected long term growth rate for CELLDEX THERAPEUTICS INC (CLDX) is 289.73%.